Back to search

Ireland· IE-PA-PA23311/001/003

Fortum 2 g powder for solution for injection or infusion

A ceftazidime product containing ceftazidime, registered in Ireland by Sandoz Pharmaceuticals d.d.. The same ATC class is registered in 18 of our 19 countries.

ATC J01DD02

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedFortum 2 g powder for solution for in…ATCJ01DD02REGISTER NO.IE-PA-PA23311/001/003PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Ceftazidime is registered in 18 of 19 countries.

Countries holding a registration under ATC J01DD02 (ceftazidime), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 10 of them publish a price we can compare per daily dose

Ceftazidime · ATC J01DD02

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ceftazidime costs, country by country.

Normalised to the WHO defined daily dose (4 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ceftazidime · price per daily dose (4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$129.98
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Ceftazidime
Manufacturer
Sandoz Pharmaceuticals d.d.
Country
Ireland (IE)
ATC code
J01DD02
ATC class
Ceftazidime
Defined daily dose
4 g, P
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA23311/001/003

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

155 interactions on record for ceftazidime.

Graded by severity as the source publishes them — 34 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ceftazidime · interactions on record

155 records

  • 34 moderate
  • 121 info

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • NeomycinA07AA01moderate
  • StreptomycinA07AA04moderate
  • Amphotericin BA07AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ceftazidime in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ceftazidime products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Ceftazidim Aptapharma, Ceftazidim Hameln
  • Belgium · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
  • Bulgaria · Алфагем, Зидимцеф
  • Cyprus · Alfagem, Cezid
  • Czechia · Altecim, Ceftazidim Aptapharma
  • Germany · Ceftazidim Dr. Eberth, Ceftazidim Hameln
  • Denmark · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
  • Estonia · Altecim, Ceftazidime Fresenius Kabi
  • Spain · Alfagem, Ceftazidima Kabi
  • Finland · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
  • France · Ceftazidime Arrow, Ceftazidime Enfants Et Nourrissons Panpharma
  • United Kingdom (Northern Ireland) · Ceftazadime, Ceftazidime Cox Pharmaceutical
  • Greece · Alfagem, Ceftaridem
  • Croatia · Altecim, Cefaz
  • Hungary · Ceftazidim Aptapharma, Ceftazidim Kabi
  • Iceland · Ceftazidim Fresenius Kabi, Ceftazidima Normon
  • Italy · Ceftazidima Almus, Ceftazidima Astro-Pharma
  • Lithuania · Biotum, Ceftazidime Kabi
  • Luxembourg · Ceftazidim Fresenius Kabi, Glazidim
  • Latvia · Ceftazidime Fresenius Kabi, Ceftazidime Mip
  • Malta · Alfagem, Ceftazidima Fresenius
  • Netherlands · Ceftazidim (Im/Iv) Mip, Ceftazidim (Iv) Mip
  • Norway · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
  • Poland · Biotum, Ceftazidim Aptapharma
  • Portugal · Alfagem, Ceftazidima Accord
  • Romania · Alfagem, Ceftamil
  • Sweden · Ceftazidim Hameln, Fortum
  • Slovenia · Ceftazidim Aptapharma, Ceftazidim Kabi
  • Slovakia · Ceftazidim Ash, Ceftazidim Hameln

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c977a4df-75c4-4f8c-96d1-5281b018bbd2
GET /v1/drugs/c977a4df-75c4-4f8c-96d1-5281b018bbd2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for injection/infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "J01DD",
    "J01DD02"
  ],
  "strength": null,
  "pa_number": "PA23311/001/003",
  "substances": [
    "Ceftazidime"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "24/09/1984",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about ceftazidime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.